We are live on ! Find out more
OPTN

OptiNose
OPTN

Delisted

OPTN was delisted on the 20th of May, 2025.

Back to rankings

72 hedge funds and large institutions have $543M invested in OptiNose in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 36 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 4

460% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 5

143% more capital invested

Capital invested by funds: $223M → $543M (+$320M)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

47% more funds holding

Funds holding: 49 → 72 (+23)

1.17% more ownership

Funds ownership: 1.98% → 3.16% (+1.2%)

Holders
72
Holders Change
+23
Holders Change %
+46.94%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
28
Increased
36
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$30.3M
2
BlackRock
BlackRock
New York
+$17.3M
3
Franklin Resources
Franklin Resources
California
+$13.6M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$13.1M
5
TA
Tamarack Advisers
California
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$6.69M
2
PCM
Peregrine Capital Management
Minnesota
-$6.36M
3
OAM
Oxford Asset Management
United Kingdom
-$1.5M
4
IBT
International Biotechnology Trust
United Kingdom
-$1.3M
5
Macquarie Group
Macquarie Group
Australia
-$538K
Name Holding Trade Value Shares
Change 		Change in
Stake
American Century Companies
26
American Century Companies
Missouri
$4.42M +$1.12M +3,337 +46%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$3.44M +$1.29M +3,829 +87%
MIM
28
Monashee Investment Management
Massachusetts
$2.8M – – –
N
29
Nuveen
North Carolina
$2.75M +$2.21M +6,565 New
State of New Jersey Common Pension Fund D
30
State of New Jersey Common Pension Fund D
New Jersey
$2.53M +$2.03M +6,032 New
Charles Schwab
31
Charles Schwab
California
$1.98M +$1.05M +3,126 +198%
MS
32
Maven Securities
Jersey
$1.4M +$782K +2,320 +229%
EGI
33
EAM Global Investors
California
$1.36M +$1.1M +3,253 New
TCIM
34
TIAA CREF Investment Management
New York
$1.31M +$1.05M +3,123 New
Morgan Stanley
35
Morgan Stanley
New York
$1.17M +$597K +1,771 +175%
EI
36
EAM Investors
California
$1.08M +$869K +2,578 New
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$1.04M +$719K +2,132 +604%
Bank of America
38
Bank of America
North Carolina
$976K +$250K +741 +47%
Two Sigma Investments
39
Two Sigma Investments
New York
$921K +$739K +2,193 New
Deutsche Bank
40
Deutsche Bank
Germany
$877K +$545K +1,618 +343%
V
41
Veritable
Delaware
$839K – – –
MCM
42
Moore Capital Management
New York
$839K +$674K +2,000 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$689K +$361K +1,070 +187%
TA
44
Teachers Advisors
New York
$670K +$538K +1,597 New
SSA
45
Schonfeld Strategic Advisors
New York
$593K +$476K +1,413 New
Swiss National Bank
46
Swiss National Bank
Switzerland
$554K +$445K +1,320 New
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$464K +$373K +1,107 New
Millennium Management
48
Millennium Management
New York
$427K +$343K +1,018 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$417K +$335K +994 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$381K +$306K +907 New
1
2
3 4

OPTN Hedge Fund Activity: Q2 2018 in Review

72 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2018, worth a combined $543M — up 143% from $223M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new OPTN positions and 5 closed out — a net gain of 23 holders — while 36 added to existing stakes and 4 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $30.3M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $6.69M sold.

  • 72 institutional investors held OptiNose (OPTN) as of Q2 2018, up from 49 in Q1 2018.
  • Funds reported $543M of OptiNose stock for Q2 2018, up 143% quarter-over-quarter.
  • 28 funds opened new OptiNose positions in Q2 2018 and 5 closed out, a net change of +23 holders.
  • The largest OptiNose buyer in Q2 2018 was JP Morgan Chase, an estimated $30.3M added.
  • The largest OptiNose seller in Q2 2018 was PFM Health Sciences, an estimated $6.69M sold.

Based on aggregated 13F filings for Q2 2018.